Save time and get answers to complex questions with AI chat
Complera manufacturer?Combivent generic equivalent?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?When is xarelto's patent set to expire roughly?Dabrafenib and trametinib price?
See the DrugPatentWatch profile for entyvio
Entyvio (vedolizumab) first received U.S. approval from the FDA in May 2014, which means it has been on the market for about 12 years as of 2026 [1].
The key date for “on the market” is FDA approval. Entyvio was approved in May 2014, so its U.S. market availability starts from that approval date [1].
Yes. “On the market” can differ by region if you mean first commercial availability worldwide rather than U.S. availability. The FDA approval date provides the clearest, consistent reference point for U.S. market entry [1]. Sources [1] https://www.drugs.com/history/entyvio.html
Other Questions About Entyvio :